Thomas
Quertermous, MD.
Tom
is the William G. Irwin Professor of Medicine and Chief of the Division
of Cardiovascular Medicine at Stanford University. He is the PI of several
research projects in this lab and labs across Stanford campus and other
research institutes.
Dr. Quertermous came to Stanford from Vanderbilt University where he served
as H. J. Morgan Professor of Medicine and Director of the Division of
Cardiology.
Dr. Quertermous received his undergraduate education at Grinnell College,
in Grinnell, Iowa., and subsequently earned an MS degree in Biophysics
and Theoretical Biology at the University of Chicago. He received his
medical degree from the University of Chicago, where he also completed
housestaff training in internal medicine.
Subsequently he moved to Boston, where he served as clinical fellow in
the Cardiac Unit at the Massachusetts General Hospital. He also completed
a research fellowship in the Department of Genetics at the Harvard Medical
School in the laboratory of Dr. Jon Seidman, and then returned to the
Massachusetts General Hospital as an attending physician and principal
laboratory investigator.
Dr. Quertermous was one of the first scientists to apply the methods of
molecular biology to the study of the physiology and pathophysiology of
the blood vessel wall. His laboratory provided fundamental insights into
the biology of the endothelin family of vasoconstrictor molecules and
employed endothelin-1 as a model of endothelial cell-specific gene expression.
Interests in the Quertermous laboratory over the past years have extended
to encompass embryonic development of the cardiovascular system, and a
number of novel genes have been cloned and linked to basic development.
Dr. Quertermous has received numerous awards and given invited
lectureships in national and international forums. He has
served as a member of study sections at the National Institutes
of Health and National American Heart Association. He is a
member of the Association of University Cardiologists, and
a member of the American Society of Clinical Investigation
(young turks). He has served on the editorial board of a number
of journals, including Circulation, and is a frequent reviewer
of manuscripts submitted to Nature and the New England Journal
of Medicine.
|
|
 |